Latest News

January 13, 2015

Debiopharm Diagnostics leads investment round in GenePOC with Emerillon Capital

September 17, 2014

Debiopharm Diagnostics portfolio company Biocartis ships its first Idylla instrument

March 5, 2014

Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group™

January 8, 2014

Spinomix announces a milestone payment from Debiopharm Group™ and the appointment of a new CEO

June 7, 2013

Diagnoplex S.A. closes a financing round led by Debiopharm Group™

January 9, 2013

Spinomix closes a $ 3 Million financing round led by Debiopharm Group™

June 19, 2012

Debiopharm, Immunexpress and Biocartis Announce Collaboration to Advance Development of SeptiCyte® Triage for Managing Sepsis

April 8, 2010

Debiopharm Group™ and Biocartis embark on a partnership aiming at enhancing personalized medicine

June 27, 2005

Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product